Want to see GB:AMS full AI Analyst Report?
Total Valuation
Advanced Medical Solutions has a market cap or net worth of £610.26M. The enterprise value is 680.02 p.
Market Cap£610.26M
Enterprise Value680.02 p
Share Statistics
Advanced Medical Solutions has 219,604,170 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding219,604,170
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Advanced Medical Solutions’s return on equity (ROE) is 0.04 and return on invested capital (ROIC) is 3.47%.
Return on Equity (ROE)0.04
Return on Assets (ROA)0.03
Return on Invested Capital (ROIC)3.47%
Return on Capital Employed (ROCE)0.06
Revenue Per Employee127.19K
Profits Per Employee5.53K
Employee Count1,800
Asset Turnover0.58
Inventory Turnover1.72
Valuation Ratios
The current PE Ratio of Advanced Medical Solutions is 163.0. Advanced Medical Solutions’s PEG ratio is 1.19.
PE Ratio163.0
PS Ratio2.05
PB Ratio1.82
Price to Fair Value1.82
Price to FCF21.97
Price to Operating Cash Flow30.00
PEG Ratio1.19
Income Statement
In the last 12 months, Advanced Medical Solutions had revenue of 228.94M and earned 9.95M in profits. Earnings per share was 0.05.
Revenue228.94M
Gross Profit108.78M
Operating Income21.99M
Pretax Income17.78M
Net Income9.95M
EBITDA43.39M
Earnings Per Share (EPS)0.05
Cash Flow
In the last 12 months, operating cash flow was 20.38M and capital expenditures -12.43M, giving a free cash flow of 7.95M billion.
Operating Cash Flow20.38M
Free Cash Flow7.95M
Free Cash Flow per Share0.04
Dividends & Yields
Advanced Medical Solutions pays an annual dividend of 2.01 p, resulting in a dividend yield of 1.66%
Dividend Per Share2.01 p
Dividend Yield1.66%
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.03
52-Week Price Change28.12%
50-Day Moving Average280.92
200-Day Moving Average237.21
Relative Strength Index (RSI)61.44
Average Volume (3m)2.37M
Important Dates
Advanced Medical Solutions upcoming earnings date is Mar 17, 2027, TBA (Confirmed).
Last Earnings DateSep 16, 2026
Next Earnings DateMar 17, 2027
Ex-Dividend Date―
Financial Position
Advanced Medical Solutions as a current ratio of 2.79, with Debt / Equity ratio of 33.60%
Current Ratio2.79
Quick Ratio1.39
Debt to Market Cap0.15
Net Debt to EBITDA1.46
Interest Coverage Ratio4.32
Taxes
In the past 12 months, Advanced Medical Solutions has paid 7.69M in taxes.
Income Tax7.69M
Effective Tax Rate0.43
Enterprise Valuation
Advanced Medical Solutions EV to EBITDA ratio is 12.29, with an EV/FCF ratio of 24.94.
EV to Sales2.33
EV to EBITDA12.29
EV to Free Cash Flow24.94
EV to Operating Cash Flow18.55
Balance Sheet
Advanced Medical Solutions has £13.56M in cash and marketable securities with £85.37M in debt, giving a net cash position of -£71.81M billion.
Cash & Marketable Securities£13.56M
Total Debt£85.37M
Net Cash-£71.81M
Net Cash Per Share-£0.33
Tangible Book Value Per Share£0.25
Margins
Gross margin is 47.94%, with operating margin of 9.61%, and net profit margin of 4.35%.
Gross Margin47.94%
Operating Margin9.61%
Pretax Margin7.77%
Net Profit Margin4.35%
EBITDA Margin18.95%
EBIT Margin9.61%
Analyst Forecast
The average price target for Advanced Medical Solutions is £275.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target£275.00
Price Target Upside-2.31% Downside
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast6.05%
EPS Growth Forecast-60.00%